Shingles Vaccine Market Report 2026
Download Free Sample Buy Now
Shingles Vaccine Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Shingles Vaccine Market Report 2026

Global Outlook – By Vaccine Type (Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine), By Product (Shingrix, Zostavax, Skyzoster), By Age Group (50-59 Years, 60-69 Years, 70 Years And Above), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End User (Hospitals, Clinics, Pharmacies) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Shingles Vaccine Market Overview

• Shingles Vaccine market size has reached to $5.55 billion in 2025

• Expected to grow to $10.96 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%

• Growth Driver: Increasing Number Of Vaccination Programs Fueling The Growth Of The Market Due To Rising Public Awareness And Improved Accessibility

• Market Trend: Innovative Recombinant Adjuvanted Vaccines Enhance Shingles Protection

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Shingles Vaccine Market?

Shingles vaccine is a preventive immunization designed to protect against shingles (herpes zoster), a painful skin rash caused by the reactivation of the varicella-zoster virus. It works by stimulating the immune system to recognize and fight against the varicella-zoster virus and helps reduce the risk of developing shingles and its associated complications.

The main types of shingles vaccines are live attenuated vaccines, recombinant vaccines, and subunit vaccines, A live attenuated vaccine is a type of vaccine that uses a weakened form of a live pathogen capable of replicating without causing disease to stimulate a strong and lasting immune response. The products types of these vaccines include shingrix, zostavax, and skyzoster and are primarily administered to age groups of 50-59 years, 60-69 years, and 70 years and above. These are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies and cater to various end users such as hospitals, clinics, and pharmacies.

Shingles Vaccine Market Global Report 2026 Market Report bar graph

What Is The Shingles Vaccine Market Size and Share 2026?

The shingles vaccine market size has grown rapidly in recent years. It will grow from $5.55 billion in 2025 to $6.37 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to limited availability of shingles vaccines, reliance on live attenuated vaccines, growing elderly population, increasing incidence of herpes zoster, rising awareness of immunization benefits.

What Is The Shingles Vaccine Market Growth Forecast?

The shingles vaccine market size is expected to see rapid growth in the next few years. It will grow to $10.96 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to development of recombinant and subunit vaccines, expansion of public and private vaccination campaigns, increasing adoption of online and retail pharmacy distribution, rising government and healthcare initiatives for elderly immunization, integration of digital health monitoring for vaccination adherence. Major trends in the forecast period include rising adoption of recombinant and subunit shingles vaccines, increasing awareness of shingles prevention among older adults, expansion of vaccination programs through hospital and retail pharmacies, growth in online pharmacies and e-commerce vaccine distribution, focus on age-specific immunization strategies for 50+ population.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Shingles Vaccine Market Segmentation

1) By Vaccine Type: Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine

2) By Product: Shingrix, Zostavax, Skyzoster

3) By Age Group: 50-59 Years, 60-69 Years, 70 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End User: Hospitals, Clinics, Pharmacies

Subsegments:

1) By Live Attenuated Vaccine: Virus Strain A, Virus Strain B, Virus Strain C

2) By Recombinant Vaccine: Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine

3) By Subunit Vaccine: Protein Subunit Vaccine, Conjugate Subunit Vaccine

What Is The Driver Of The Shingles Vaccine Market?

The increasing number of vaccination programs is expected to propel the growth of the shingles vaccine market going forward. Vaccination programs refer to organized public health initiatives designed to systematically administer vaccines to populations in order to prevent the spread of infectious diseases. The number of vaccination programs is increasing due to rising awareness about preventive healthcare, encouraging more people to get vaccinated to avoid diseases. Vaccination programs enhance shingles vaccine adoption by increasing public awareness and accessibility, making them ideal for older adults and high-risk populations. They reduce the risk of shingles and related complications by promoting timely and widespread immunization, improving overall community health. For instance, in July 2025, according to the World Health Organization, a Switzerland-based Intergovernmental organization, the coverage for the first dose of human papillomavirus (HPV) vaccine in girls increased from 27% in 2023 to 31% in 2024. Therefore, the increasing number of vaccination programs is driving the growth of the shingles vaccine industry.

Key Players In The Global Shingles Vaccine Market

Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc

Global Shingles Vaccine Market Trends and Insights

Major companies operating in the shingles vaccine market are focusing on developing innovative vaccine formulations, such as recombinant adjuvanted vaccines, to enhance immune response and provide long-lasting protection against shingles. Recombinant adjuvanted vaccines use lab-made viral proteins combined with substances called adjuvants to boost the body's immune response for better and longer-lasting protection. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Shingrix, a shingles vaccine. Shingrix is a non-live, recombinant adjuvanted subunit vaccine administered intramuscularly in two doses for adults aged 50 and above, designed to prevent shingles (herpes zoster) and its related complication, post-herpetic neuralgia. This highly effective vaccine provides over 90% protection against shingles, with strong and sustained immunity lasting at least 10 years, even in older adults and immunocompromised individuals.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Shingles Vaccine Market?

In October 2023, GSK plc, a UK-based healthcare technology company, partnered with Chongqing Zhifei Biological Products Co. Ltd. to establish an exclusive vaccine distribution and co-promotion agreement in China. With this partnership, GSK and Zhifei aim to significantly expand access to GSK’s shingles vaccine (Shingrix) across over 30,000 vaccination points in China while building a long-term foundation to potentially co-develop and commercialize GSK’s RSV vaccine (Arexvy) for older adults in the Chinese market. Chongqing Zhifei Biological Products Co. Ltd. is a China-based biotechnology company that specializes in the development, manufacture, and distribution of innovative vaccines.

Regional Insights

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Shingles Vaccine Market?

The shingles vaccine market consists of sales of vaccine kits, cold chain storage equipment, pre-filled syringes, vaccine delivery devices, and temperature monitoring systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Shingles Vaccine Market Report 2026?

The shingles vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the shingles vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Shingles Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.37 billion
Revenue Forecast In 2035 $10.96 billion
Growth Rate CAGR of 14.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Vaccine Type, Product, Age Group, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Shingles Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Shingles Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Shingles Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Shingles Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Recombinant And Subunit Shingles Vaccines

4.2.2 Increasing Awareness Of Shingles Prevention Among Older Adults

4.2.3 Expansion Of Vaccination Programs Through Hospital And Retail Pharmacies

4.2.4 Growth In Online Pharmacies And E-Commerce Vaccine Distribution

4.2.5 Focus On Age-Specific Immunization Strategies For 50+ Population

5. Shingles Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Pharmacies

5.4 Online Pharmacies

5.5 Elderly Care Centers

6. Shingles Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Shingles Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Shingles Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Shingles Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Shingles Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Shingles Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Shingles Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Shingles Vaccine Market Segmentation

9.1. Global Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine

9.2. Global Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Shingrix, Zostavax, Skyzoster

9.3. Global Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50-59 Years, 60-69 Years, 70 Years And Above

9.4. Global Shingles Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

9.5. Global Shingles Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Pharmacies

9.6. Global Shingles Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Virus Strain A, Virus Strain B, Virus Strain C

9.7. Global Shingles Vaccine Market, Sub-Segmentation Of Recombinant Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine

9.8. Global Shingles Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Subunit Vaccine, Conjugate Subunit Vaccine

10. Shingles Vaccine Market Regional And Country Analysis

10.1. Global Shingles Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Shingles Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Shingles Vaccine Market

11.1. Asia-Pacific Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Shingles Vaccine Market

12.1. China Shingles Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Shingles Vaccine Market

13.1. India Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Shingles Vaccine Market

14.1. Japan Shingles Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Shingles Vaccine Market

15.1. Australia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Shingles Vaccine Market

16.1. Indonesia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Shingles Vaccine Market

17.1. South Korea Shingles Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Shingles Vaccine Market

18.1. Taiwan Shingles Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Shingles Vaccine Market

19.1. South East Asia Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Shingles Vaccine Market

20.1. Western Europe Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Shingles Vaccine Market

21.1. UK Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Shingles Vaccine Market

22.1. Germany Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Shingles Vaccine Market

23.1. France Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Shingles Vaccine Market

24.1. Italy Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Shingles Vaccine Market

25.1. Spain Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Shingles Vaccine Market

26.1. Eastern Europe Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Shingles Vaccine Market

27.1. Russia Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Shingles Vaccine Market

28.1. North America Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Shingles Vaccine Market

29.1. USA Shingles Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Shingles Vaccine Market

30.1. Canada Shingles Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Shingles Vaccine Market

31.1. South America Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Shingles Vaccine Market

32.1. Brazil Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Shingles Vaccine Market

33.1. Middle East Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Shingles Vaccine Market

34.1. Africa Shingles Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Shingles Vaccine Market, Segmentation By Vaccine Type, Segmentation By Product, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Shingles Vaccine Market Regulatory and Investment Landscape

36. Shingles Vaccine Market Competitive Landscape And Company Profiles

36.1. Shingles Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Shingles Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Shingles Vaccine Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GSK plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. SK bioscience Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GeneOne Life Science Overview, Products and Services, Strategy and Financial Analysis

37. Shingles Vaccine Market Other Major And Innovative Companies

Curevo Inc, Novavax Inc

38. Global Shingles Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Shingles Vaccine Market

40. Shingles Vaccine Market High Potential Countries, Segments and Strategies

40.1 Shingles Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Shingles Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Shingles Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Shingles Vaccine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Shingles Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Shingles Vaccine Market, Supply Chain Analysis
  • Table 4: Global Shingles Vaccine Market, Major Raw Material Providers
  • Table 5: Global Shingles Vaccine Market, Major Resource Providers
  • Table 6: Global Shingles Vaccine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Shingles Vaccine Market, Major Distributors And Channel Partners
  • Table 8: Global Shingles Vaccine Market, Key Technologies & Future Trends
  • Table 9: Global Shingles Vaccine Market, Major Trends
  • Table 10: Global Shingles Vaccine Market, Major End Users
  • Table 11: Global Shingles Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Shingles Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Shingles Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Shingles Vaccine Market - TAM, US$ Billion, 2025
  • Table 15: Global Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Shingles Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Shingles Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Shingles Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Shingles Vaccine Market, Sub-Segmentation Of Recombinant Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Shingles Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Shingles Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Shingles Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Shingles Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Shingles Vaccine Market - Company Scoring Matrix
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: GSK plc Financial Performance
  • Table 101: SK bioscience Financial Performance
  • Table 102: Pfizer Inc Financial Performance
  • Table 103: GeneOne Life Science Financial Performance
  • Table 104: Global Shingles Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Shingles Vaccine Market, Competitive Dashboard
  • Table 106: Global Shingles Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Shingles Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Table 108: Global, Shingles Vaccine Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 109: Global, Shingles Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

    Figure 1: Global Shingles Vaccine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Shingles Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Shingles Vaccine Market, Supply Chain Analysis
  • Figure 4: Global Shingles Vaccine Market, Major Raw Material Providers
  • Figure 5: Global Shingles Vaccine Market, Major Resource Providers
  • Figure 6: Global Shingles Vaccine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Shingles Vaccine Market, Major Distributors And Channel Partners
  • Figure 8: Global Shingles Vaccine Market, Key Technologies & Future Trends
  • Figure 9: Global Shingles Vaccine Market, Major Trends
  • Figure 10: Global Shingles Vaccine Market, Major End Users
  • Figure 11: Global Shingles Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Shingles Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Shingles Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Shingles Vaccine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Shingles Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Shingles Vaccine Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Shingles Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Shingles Vaccine Market, Sub-Segmentation Of Recombinant Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Shingles Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Shingles Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Shingles Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Shingles Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Shingles Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Shingles Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Shingles Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Shingles Vaccine Market - Company Scoring Matrix
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: GSK plc Financial Performance
  • Figure 101: SK bioscience Financial Performance
  • Figure 102: Pfizer Inc Financial Performance
  • Figure 103: GeneOne Life Science Financial Performance
  • Figure 104: Global Shingles Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Shingles Vaccine Market, Competitive Dashboard
  • Figure 106: Global Shingles Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Shingles Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Figure 108: Global, Shingles Vaccine Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 109: Global, Shingles Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Construction Market Report 2026 - Global Outlook – By Type Of Construction (Buildings Construction, Heavy And Civil Engineering Construction, Specialty Trade Contractors, Land Planning And Development), By Type Of Contra...

Folding Furniture Market Report 2026 - Global Outlook – By Product Type (Chairs, Tables, Sofas, Beds, Other Product Types), By Material (Wood, Metal, Plastic), By Distribution Channel (Offline, Online), By Application (R...

Foldable Houses Market Report 2026 - Global Outlook – By Construction Type (Single Section, Multi-Section), By Architecture Type (Slope Roof, Flat Roof), By End-User (Single Family, Multi-Family) – Market Size, Trends, S...

Excavation And Demolition Market Report 2026 - Global Outlook – By Type (Building Construction, Heavy And Civil Engineering Construction, Specialty Trade Contractors, Land Planning And Development), By Equipment Type (Ea...

Construction Fabrics Market Report 2026 - Global Outlook – By Type (Woven, Non-Woven, Other Types), By Material (Polyester, Nylon, PTFE (Polytetrafluoroethylene), Silicone Glass, ETFE (Ethylene Tetrafluoroethylene), Othe...

Building Panels Market Report 2026 - Global Outlook – By Panel Type (Precast Concrete Panels, Vacuum Insulated Panels, Structural Insulated Panels (SIP), Wood-Based Panels, Other Panel Type), By Material Type (Concrete, ...

Site Preparation Contractors Market Report 2026 - Global Outlook – By Product (Site Clearing Tools, Surveying Tools, Soil Testing Tools, Erosion Control Materials), By Equipment (Excavators, Loaders, Dump Trucks, Bulldoz...

Construction Elastomers Market Report 2026 - Global Outlook – By Type (Thermoset, Thermoplastic ), By Chemistry (Styrene Block Copolymers (SBCS), Thermoplastic Polyurethanes (TPU), Styrene-Butadiene (SBR), Ethylene Propy...

Frequently Asked Questions

The Shingles Vaccine market was valued at $5.55 billion in 2025, increased to $6.37 billion in 2026, and is projected to reach $10.96 billion by 2030.

The global Shingles Vaccine market is expected to grow at a CAGR of 14.5% from 2026 to 2035 to reach $10.96 billion by 2035.

Some Key Players in the Shingles Vaccine market Include, Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc .

Major trend in this market includes: Innovative Recombinant Adjuvanted Vaccines Enhance Shingles Protection. For further insights on this market. request a sample here

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us